2024 Pharma Outlook Report
Don't miss out on a sector that has $1.37 trillion in available capital for M&A!
The Investing News Network (INN) spoke with analysts, market watchers and insiders about which trends will impact this sector.
| ✓ Trends | ✓ Forecasts | ✓ Top Stocks |
Table of Contents:
|  |
A Sneak Peek At What The Insiders Are Saying
There is every reason to expect biopharma dealmaking to continue and accelerate. Despite its increased dealmaking activity, the sector retains more than US$1.37 trillion in available capital for M&A."
— Subin Baral, EY
"To outperform in this environment, leading (pharma) companies can seize this moment to 'reinvent for returns.' Companies with foresight will see 2024 as the year of delivering impressive results for both patients and investors."
— PWC
Who We Are
The Investing News Network is a growing network of authoritative publications delivering independent, unbiased news and education for investors. We deliver knowledgeable, carefully curated coverage of a variety of markets including gold, cannabis, biotech and many others. This means you read nothing but the best from the entire world of investing advice, and never have to waste your valuable time doing hours, days or weeks of research yourself.
At the same time, not a single word of the content we choose for you is paid for by any company or investment advisor: We choose our content based solely on its informational and educational value to you, the investor.
So if you are looking for a way to diversify your portfolio amidst political and financial instability, this is the place to start. Right now.